Diffusion Length of Local Anesthetics in the Subparaneural Space and Duration of Analgesia
The Correlation Between the Diffusion Length of Local Anesthetics in the Subparaneural Space and Duration of Analgesia for Patients Receiving Sciatic Block
1 other identifier
interventional
90
1 country
1
Brief Summary
Ultrasound-guided popliteal sciatic nerve block is a widely practiced technique to provide anesthesia or analgesia for below-knee surgeries. One study named the space between paraneural sheath and epimysium of sciatic nerve as the subparaneural space. It has been reported that injection into the subparaneural space has several advantages (improved the quality of the sensory block and resulted in a longer block duration) over conventional perineural injection. The investigators conducted this prospective randomized study to test the hypothesis that, during ultrasound-guided single popliteal sciatic nerve block, diffusion length of local anesthetics in the subparaneural space could predict anesthetic effect and duration of analgesia. The results of this study will develop a novel indicator to facilitate personalized medicine for patients receiving sciatic block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2022
CompletedFirst Posted
Study publicly available on registry
June 29, 2022
CompletedStudy Start
First participant enrolled
July 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2025
CompletedJuly 19, 2022
July 1, 2022
3 years
June 18, 2022
July 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Diffusion length of ropivacaine and duration of analgesia
The relationship of diffusion length of 0.5% ropivacaine in the subparaneural space and duration of analgesia(sensory block time)
3 days
Secondary Outcomes (1)
Diffusion length of ropivacaine and duration of motor block time
3 days
Study Arms (1)
Diffusion length and anesthetic effect
EXPERIMENTALdiffusion length of local anesthetics in the subparaneural space could predict anesthetic effect and duration of analgesia
Interventions
Ropivacaine 20 ml injection into the subparaneural space of sciatic nerve
Eligibility Criteria
You may qualify if:
- scheduled for elective below-knee surgery under general anesthesia combined with peripheral nerve block were included. Their physical status was rated I to II by the criteria of the American Society of Anesthesiologists (ASA).
You may not qualify if:
- clinically significant coagulopathy, infection at the injection site, allergy to the local anesthetics, severe cardiopulmonary disease (NYHA ≥III), a body mass index \> 35kg/m2, diabetic or other neuropathy, prior surgery in the popliteal region, or receiving opioids for chronic analgesic therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750004, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2022
First Posted
June 29, 2022
Study Start
July 30, 2022
Primary Completion
July 29, 2025
Study Completion
July 29, 2025
Last Updated
July 19, 2022
Record last verified: 2022-07